The 52-Week-High List: 12 Small Cap Names On Friday
A short list of breakouts shows a wide gap between steady climbers and explosive movers.
As of Friday, September 25, there are 12 Small Cap US and Canada-listed stocks in the Trefis coverage universe trading at their 52-week highs. The S&P 500 has returned +1.0% over the last month, making this a narrow list of standouts.
The group includes GRAIL (GRAL), which gained 59.4% in a month, alongside the largest name, Avnet (AVT), which gained 14.6%. This raises a key question: what kind of business strength supports these very different paths to a new high?
The 10 Largest, By Market Cap
The table below shows the 10 largest of the 12 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| AVT | $8.47 Bil | 2.1% | 7.2% | 14.6% | 99.1% |
| HNGE | $7.55 Bil | 3.9% | 0.7% | 5.6% | 76.2% |
| ACA | $7.2 Bil | 0.1% | 0.5% | 0.9% | 56.4% |
| GRAL | $5.47 Bil | 1.3% | 57.1% | 59.4% | 172.4% |
| IOVA | $4.95 Bil | 1.9% | 7.3% | 36.1% | 418.9% |
| BATRA | $3.79 Bil | 0.3% | 5.7% | 4.4% | 30.0% |
| CDNA | $3.28 Bil | 3.8% | 18.3% | 25.0% | 322.8% |
| ATKR | $3.19 Bil | 0.0% | 0.3% | 1.0% | 57.8% |
| IMAX | $3.08 Bil | 1.6% | 6.2% | 6.2% | 73.7% |
| IOSP | $2.43 Bil | 1.9% | 6.0% | 3.2% | 28.6% |
This screen covers US and Canada-listed stocks in the Trefis coverage universe. Small Cap here means a market value between $2 billion and $10 billion, the upper figure excluded.
Which names show the business growth to earn these new highs?
The list contains very different profiles. Avnet (AVT) trades at 25.3 times trailing earnings, and its revenue grew 24.5% over the last twelve months, and its operating margin was 3.1%. Another large name, Arcosa (ACA), trades at 14.7 times trailing earnings, and its revenue grew 9.7% over the last twelve months, and its operating margin was 11.8%.
Then there is Hinge Health (HNGE). It trades at 69.2 times trailing earnings, on trailing earnings that include at least one loss quarter, so the multiple is not comparable to a clean-year multiple. Its revenue grew 49.8% over the last twelve months, and its operating margin was 13.0%.
How should an investor use a 52-week-high list?
Strength often persists, and stocks reaching new highs can continue to climb. But a high is a price, not a verdict. It marks a moment where the market is optimistic, and nothing more.
The disciplined move is to treat the list as a starting point for work, not a finish line. The real question is whether the business fundamentals, from revenue growth to operating margins, can support the stock at its new level.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks.
Strength Is A Clue. It Is Not A Plan
A stock at its 52-week high has momentum on its side, and momentum is a real force. It is also the most crowded signal in the market, and what separates a run that lasts from one that tops is usually the business underneath.
Checking that business, across thousands of names, is how the Trefis High Quality (HQ) Portfolio is assembled: roughly 30 companies that pass the quality screens, rebalanced on rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Let the highs point; let the discipline decide.